TP53 and cancer: LFS is suspected based on phenotype criteria and confirmed by identifying a pathogenic germline variant in TP53, however, germline mutations may be missing in some families with characteristic LFS patterns of cancer, and conversely as many as 20% of patients have de novo mutations and are thus without a LFS pattern family history of cancer [6].